Pre-surgery chemo for advanced stomach cancer with lymph spread
Part of Cancer, Digestive system clinical trials.
This Phase 2 study tests a combination chemotherapy regimen given before surgery for stomach cancer that cannot be fully removed (unresectable), including spread to lymph nodes. The goal is to shrink the cancer and improve control with a well-known set of medicines given in a specific order.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stomach cancer that is confirmed as adenocarcinoma by a pathology report or lab test
- Your cancer is advanced and cannot be fully removed: it’s either invaded nearby organs (T4) or has spread to lymph nodes (specific CT measurements)
- You are older than 18, and you can be expected to live at least 3 more months
- Your general health score is 0 or 1 (meaning you’re able to care for yourself fairly well)
- You have enough blood counts and organ function on labs (including blood, white cells, platelets, liver, and kidney test results)
- You have never had chemotherapy before, and you haven’t had radiation therapy before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called zolbetuximab combined with chemotherapy (docetaxel, oxaliplatin, S-1) before surgery for people with locally advanced stomach cancer that has a specific protein (CLDN18.2). The goal is to see if this combination shrinks tumors enough to improve surgery outcomes.
This trial tests a combination of chemotherapy drugs given before surgery for locally advanced stomach or gastroesophageal junction cancer. It aims to see if this approach helps shrink the tumor and improve outcomes.
This trial tests combining chemotherapy, immunotherapy, and radiation before surgery for stomach or gastroesophageal junction cancer that has spread to a limited number of sites. The goal is to see if this approach can improve outcomes by shrinking tumors before they are removed.
This trial tests whether combining different drugs before and after surgery can help people with locally advanced stomach cancer that can't be removed right away. The goal is to see which combination works best to shrink the tumor and improve outcomes.
This Phase 3 trial tests which combination of chemotherapy works better after surgery for stage IIIB/IV stomach or stomach–esophagus junction adenocarcinoma. Participants get randomized to one of two chemotherapy plans to see which helps people live longer and/or prevents cancer from coming back.
This trial tests a combination chemotherapy plan—paclitaxel (albumin-bound), oxaliplatin, and S-1 given before surgery—to try to shrink stomach cancer and improve the chance of successful tumor removal. It is for people whose cancer is locally advanced or has spread, but might still be resectable (removable) in certain cases.
Hear when a new Stomach Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.